Addus Homecare (ADUS) Given Daily Coverage Optimism Rating of 0.19

News coverage about Addus Homecare (NASDAQ:ADUS) has been trending somewhat positive on Saturday, Accern Sentiment Analysis reports. Accern identifies positive and negative press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Addus Homecare earned a media sentiment score of 0.19 on Accern’s scale. Accern also assigned media stories about the company an impact score of 44.4318285265282 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

Shares of ADUS stock opened at $45.45 on Friday. The company has a quick ratio of 2.90, a current ratio of 2.90 and a debt-to-equity ratio of 0.23. The firm has a market capitalization of $502.45, a price-to-earnings ratio of 38.85, a PEG ratio of 1.57 and a beta of 0.13. Addus Homecare has a twelve month low of $29.90 and a twelve month high of $46.10.

How to Become a New Pot Stock Millionaire

Addus Homecare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, March 5th. The company reported $0.42 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.39 by $0.03. The business had revenue of $111.96 million during the quarter, compared to analyst estimates of $110.82 million. Addus Homecare had a return on equity of 9.95% and a net margin of 3.20%. analysts forecast that Addus Homecare will post 1.83 EPS for the current year.

Several brokerages have recently weighed in on ADUS. BidaskClub upgraded Addus Homecare from a “sell” rating to a “hold” rating in a report on Thursday, February 8th. Zacks Investment Research upgraded Addus Homecare from a “strong sell” rating to a “hold” rating in a report on Tuesday, January 9th. Finally, Robert W. Baird set a $43.00 price objective on Addus Homecare and gave the company a “hold” rating in a report on Wednesday, March 14th. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus price target of $42.33.

In other news, insider James Zoccoli sold 725 shares of the company’s stock in a transaction on Monday, February 26th. The stock was sold at an average price of $35.90, for a total value of $26,027.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO R Dirk Allison sold 749 shares of the company’s stock in a transaction on Monday, January 22nd. The shares were sold at an average price of $38.85, for a total value of $29,098.65. Following the completion of the sale, the chief executive officer now owns 33,120 shares of the company’s stock, valued at approximately $1,286,712. The disclosure for this sale can be found here. In the last 90 days, insiders sold 7,109 shares of company stock valued at $258,061. Insiders own 35.80% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This piece was originally published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece on another site, it was illegally copied and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this piece can be viewed at https://www.tickerreport.com/banking-finance/3294805/addus-homecare-adus-given-daily-coverage-optimism-rating-of-0-19.html.

About Addus Homecare

Addus HomeCare Corporation is a provider of personal care services, which are provided primarily in the home. The Company’s personal care services include assistance with bathing, grooming, oral care, skincare, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping and transportation services and other activities of daily living.

Insider Buying and Selling by Quarter for Addus Homecare (NASDAQ:ADUS)

Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Financial Review: Carvana  versus Its Competitors
Financial Review: Carvana versus Its Competitors
Brokerages Set Callon Petroleum  PT at $16.42
Brokerages Set Callon Petroleum PT at $16.42
Analyzing Paychex  and Forrester Research
Analyzing Paychex and Forrester Research
Head to Head Contrast: Aspen Group  versus The Competition
Head to Head Contrast: Aspen Group versus The Competition
Contrasting Rogers  & AdvanSix
Contrasting Rogers & AdvanSix
SSLJ.Com  Downgraded by ValuEngine
SSLJ.Com Downgraded by ValuEngine


© 2006-2018 Ticker Report. Google+.